# Palivizumab (Genetical Recombination) I.M. Injection (シナジス筋注液５０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6250404A1020). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6250404A1020
- **Product name (Japanese):** シナジス筋注液５０ｍｇ
- **English title:** Palivizumab (Genetical Recombination) I.M. Injection
- **Active ingredient:** パリビズマブ（遺伝子組換え）
- **Active ingredient (INN):** Palivizumab (Genetical Recombination)
- **Strength / unit:** ５０ｍｇ０．５ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 62 Chemotherapeutics (化学療法剤) › 625 Antivirals (抗ウイルス剤)
- **Manufacturer:** AstraZeneca (アストラゼネカ)
- **NHI price (reference only):** JPY 48325 per ５０ｍｇ０．５ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6250404A1020
- **JSON:** https://www.nifujipharma.com/api/drugs/6250404A1020

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Palivizumab%20(Genetical%20Recombination)%20I.M.%20Injection%20(%E3%82%B7%E3%83%8A%E3%82%B8%E3%82%B9%E7%AD%8B%E6%B3%A8%E6%B6%B2%EF%BC%95%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%206250404A1020#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Palivizumab (Genetical Recombination)

- [Palivizumab (Genetical Recombination) I.M. Injection (シナジス筋注液１００ｍｇ)](https://www.nifujipharma.com/drugs/6250404A2026) — １００ｍｇ１ｍＬ１瓶, AstraZeneca